Stay updated on Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision marker changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record page currently displays a 403 Forbidden error, preventing access to the trial details. This is a page-level access issue rather than a change to the study content.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating the content is blocked or unavailable. The error view includes the site header, navigation, and footer as part of the default error page.SummaryDifference23%

- Check56 days agoChange DetectedAn NIH grant/contract entry was added to the study record, indicating NIH funding for the trial. The page’s revision metadata was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page version. This change does not modify the study information.SummaryDifference0.0%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial page.